Friday, March 13, 2026

​

​​

​​

​​​

​​

Industry-Sponsored Satellite Symposium

13.00 - 13.30 hrs​

​

Bringing T-Cell Engager to the Treatment of Prostate Cancer as a “Cold Tumor” – What can we learn from Multiple Myeloma?

​​

13.00–13.10

Bispecific Antibodies and T-Cell Engagers in Multiple Myeloma – Experiences and Challenges

Marion Högner, Munich, Germany

​​

13.10 – 13.20

T-Cell Engager as new “Game Changer” in Prostate Cancer?

Gunhild von Amsberg, Hamburg, Germany

​

13.20 – 13.30

Discussion & Interdisciplinary Exchange